Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Researchers trying to 'bring smiles back' to kids with rare cancer

Researchers trying to 'bring smiles back' to kids with rare cancer

Stories Feb 21, 2016 3 minutes

Engineered antibodies being investigated as novel therapy for aggressive Ewing sarcoma.

When Vancouver Coastal Health Research Institute (VCHRI) scientist Dr. Horacio Bach was approached by Dr. Thomas Grünewald from the Ludwig Maximilians University of Munich, Institute of Pathology, to help him find possible antibody therapies for Ewing sarcoma – an aggressive cancer that affects mostly children and adolescents – Dr. Bach was moved by his intentions.

“Dr. Grünewald said, ‘Many of these kids are going to die because of this disease – the reason I work on this is because I will do anything just to bring smiles back to their faces,’” shares Dr. Bach, manager of the Antibody Engineering Facility within the Immunity and Infectious Research Centre at VCHRI. 

Ewing sarcoma forms in bone or soft tissue and is a rare disease.  Incidence for all ages in the United States are one case per one million people, and in 9-10 cases per one million people in patients aged 10 to 191. Upon diagnosis, approximately one in four patients will have a form of the disease that has already spread to other parts of the body2. Ewing sarcoma patients are often treated with chemotherapy, which comes with serious side effects.

Dr. Bach and the Antibody Engineering Facility work with researchers and industry to provide antibody engineering services based on single-chain antibodies (scFvs), which are molecules purposely designed to attach to specific weaknesses or defects in target cells, such as cancer cells. ScFvs are specifically amplified parts of antibodies naturally produced by the body’s immune system in response to germs, vaccines, and other foreign entities.

Dr. Bach is working on Dr. Grünewald’s suggestion to develop antibodies against a membranal protein that’s highly expressed in Ewing sarcoma.

“We’re trying to develop this antibody that can be injected and circulate and target only the cells that contain this protein on the membrane,” explains Dr. Bach, who is also an adjunct professor in the Division of Infectious Diseases, Faculty of Medicine, at the University of British Columbia. 

“We hope to develop an antibody that will kill all these specific cancer cells like focal targets, meaning other cells that don’t have this particular Ewing sarcoma protein will not be affected.”

“We use a repertoire of all of the potential antibodies that can be produced by the body in a lifetime, without potential problems of toxicity,” he says.

While there is not much funding for a disease as rare as Ewing sarcoma, the researchers’ work is currently funded by two grants. Dr. Bach received a grant from the B.C.-based Rare Disease Foundation, and Dr. Grünewald recently received funding from the Daimler and Benz Foundation in cooperation with the Reinhard-Frank Foundation.

“Eventually, it will be great to have some form of treatment, or even a cure, that can allow these children to enjoy and prolong their lives,” says Dr. Bach. “I want to be part of this research to show that just because it’s a rare disease that’s not studied or funded much, it doesn’t mean we can’t do anything.” 

 

1 National Canacer Institute - Ewing Sarcoma Treatment–for health professionals (PDQ®)

2 Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data 

Researchers

Horacio Bach

Related Articles

Causes of forearm fractures differ between boys and girls

Surgical screw cutter a promising device for orthopaedic care in developing countries

Kids can jump, skip, spring, and run their way to stronger bones

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Immunity and Infection Research Centre

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy